Surmodics, Inc. – NASDAQ:SRDX

Surmodics stock price today

$37.34
-2.09
-5.32%
Financial Health
0
1
2
3
4
5
6
7
8
9

Surmodics stock price monthly change

-6.47%
month

Surmodics stock price quarterly change

-6.47%
quarter

Surmodics stock price yearly change

+6.57%
year

Surmodics key metrics

Market Cap
565.76M
Enterprise value
337.67M
P/E
-10.13
EV/Sales
3.31
EV/EBITDA
-20.09
Price/Sales
3.23
Price/Book
3.07
PEG ratio
0.01
EPS
0.46
Revenue
139.60M
EBITDA
24.09M
Income
6.55M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-31.71%
Oper. margin
-25.4%
Gross margin
28.54%
EBIT margin
-25.4%
EBITDA margin
17.26%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Surmodics stock price history

Surmodics stock forecast

Surmodics financial statements

Surmodics, Inc. (NASDAQ:SRDX): Profit margin
Mar 2023 27.19M -7.73M -28.43%
Jun 2023 52.48M 7.34M 14%
Sep 2023 27.97M 6.69M 23.93%
Mar 2024 31.95M 247K 0.77%
Surmodics, Inc. (NASDAQ:SRDX): Analyst Estimates
Sep 2025 35.35M 980.55K 2.77%
Oct 2025 35.28M 691.01K 1.96%
Dec 2025 35.00M -1.22M -3.5%
Mar 2026 32.92M -2.10M -6.39%
  • Analysts Price target

  • Financials & Ratios estimates

Surmodics, Inc. (NASDAQ:SRDX): Debt to assets
Mar 2023 166163000 63.60M 38.28%
Jun 2023 188901000 76.48M 40.49%
Sep 2023 185733000 65.82M 35.44%
Mar 2024 182805000 58.85M 32.2%
Surmodics, Inc. (NASDAQ:SRDX): Cash Flow
Mar 2023 -5.82M -723K -794K
Jun 2023 25.89M -470K -19K
Sep 2023 1.25M -4.65M 419K
Mar 2024 7.41M 2.79M -405K

Surmodics alternative data

Surmodics, Inc. (NASDAQ:SRDX): Employee count
Aug 2023 447
Sep 2023 447
Oct 2023 447
Nov 2023 447
Dec 2023 376
Jan 2024 376
Feb 2024 376
Mar 2024 376
Apr 2024 376
May 2024 376
Jun 2024 376
Jul 2024 376

Surmodics other data

47.05% -45.22%
of SRDX is owned by hedge funds
6.57M -6.26M
shares is hold by hedge funds

Surmodics, Inc. (NASDAQ:SRDX): Insider trades (number of shares)
Period Buy Sel
Nov 2024 0 7009
Transaction Date Insider Security Shares Price per share Total value Source
Sale
ARENS TIMOTHY J. officer: Chief Fi.. Common Stock 7,009 $39.44 $276,456
Option
STICH JOSEPH J. officer: SVP of H.. Common Stock 21,285 $33.2 $706,662
Option
STICH JOSEPH J. officer: SVP of H.. Employee Stock Option (right to buy) 21,285 $33.2 $706,662
Option
MAHARAJ GARY R director, officer.. Common Stock 61,017 $33.2 $2,025,764
Option
MAHARAJ GARY R director, officer.. Employee Stock Option (right to buy) 61,017 $33.2 $2,025,764
Option
OLSON CHARLES W officer: SVP, Medical Device Co..
Common Stock 18,447 $33.2 $612,440
Option
OLSON CHARLES W officer: SVP, Medical Device Co..
Employee Stock Option (right to buy) 18,447 $33.2 $612,440
Option
ARENS TIMOTHY J. officer: Chief Fi.. Common Stock 18,447 $33.2 $612,440
Option
ARENS TIMOTHY J. officer: Chief Fi.. Employee Stock Option (right to buy) 18,447 $33.2 $612,440
Option
BEDOYA JOSE H director
Common Stock 3,932 $23.95 $94,171
Patent
Application
Filling date: 7 Jan 2022 Issue date: 14 Jul 2022
Application
Filling date: 21 Mar 2022 Issue date: 7 Jul 2022
Grant
Filling date: 15 Nov 2019 Issue date: 12 Apr 2022
Grant
Filling date: 30 Mar 2017 Issue date: 22 Mar 2022
Grant
Filling date: 16 May 2014 Issue date: 15 Feb 2022
Grant
Filling date: 28 Feb 2020 Issue date: 4 Jan 2022
Grant
Filling date: 8 Jul 2019 Issue date: 16 Nov 2021
Application
Filling date: 5 Jun 2019 Issue date: 28 Oct 2021
Grant
Filling date: 14 Dec 2017 Issue date: 21 Sep 2021
Application
Filling date: 10 May 2021 Issue date: 26 Aug 2021
Monday, 9 December 2024
zacks.com
Tuesday, 12 November 2024
zacks.com
Thursday, 7 November 2024
zacks.com
Wednesday, 6 November 2024
zacks.com
Wednesday, 30 October 2024
businesswire.com
Wednesday, 2 October 2024
zacks.com
Friday, 6 September 2024
zacks.com
Thursday, 5 September 2024
zacks.com
Thursday, 15 August 2024
zacks.com
Wednesday, 31 July 2024
zacks.com
zacks.com
Monday, 8 July 2024
globenewswire.com
Wednesday, 3 July 2024
prnewswire.com
Tuesday, 11 June 2024
zacks.com
Monday, 10 June 2024
businesswire.com
Friday, 31 May 2024
zacks.com
zacks.com
Thursday, 30 May 2024
accesswire.com
Wednesday, 29 May 2024
prnewswire.com
investors.com
prnewswire.com
businesswire.com
businesswire.com
Monday, 20 May 2024
zacks.com
Friday, 3 May 2024
Zacks Investment Research
Wednesday, 1 May 2024
Zacks Investment Research
Zacks Investment Research
Friday, 19 April 2024
Business Wire
Tuesday, 9 April 2024
Zacks Investment Research
Wednesday, 20 March 2024
Zacks Investment Research
  • What's the price of Surmodics stock today?

    One share of Surmodics stock can currently be purchased for approximately $37.34.

  • When is Surmodics's next earnings date?

    Unfortunately, Surmodics's (SRDX) next earnings date is currently unknown.

  • Does Surmodics pay dividends?

    No, Surmodics does not pay dividends.

  • How much money does Surmodics make?

    Surmodics has a market capitalization of 565.76M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 4.91% to 126.08M US dollars.

  • What is Surmodics's stock symbol?

    Surmodics, Inc. is traded on the NASDAQ under the ticker symbol "SRDX".

  • What is Surmodics's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Surmodics?

    Shares of Surmodics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Surmodics's key executives?

    Surmodics's management team includes the following people:

    • Mr. Gary R. Maharaj Chief Executive Officer, Pres & Director(age: 62, pay: $1,290,000)
    • Ms. Teryl L. W. Sides Senior Vice President of Product Devel. & Chief Marketing Officer(age: 55, pay: $638,670)
    • Mr. Gordon S. Weber Senior Vice President of Legal, Gen. Counsel & Sec.(age: 62, pay: $573,670)
    • Mr. Timothy J. Arens Senior Vice President of Fin. & Information Technology and Chief Financial Officer(age: 58, pay: $572,000)
    • Mr. Joseph J. Stich Senior Vice President and GM of HR & In Vitro Diagnostics(age: 60, pay: $570,920)
  • How many employees does Surmodics have?

    As Jul 2024, Surmodics employs 376 workers.

  • When Surmodics went public?

    Surmodics, Inc. is publicly traded company for more then 27 years since IPO on 4 Mar 1998.

  • What is Surmodics's official website?

    The official website for Surmodics is surmodics.com.

  • Where are Surmodics's headquarters?

    Surmodics is headquartered at 9924 West 74th Street, Eden Prairie, MN.

  • How can i contact Surmodics?

    Surmodics's mailing address is 9924 West 74th Street, Eden Prairie, MN and company can be reached via phone at +95 2 500 7000.

Surmodics company profile:

Surmodics, Inc.

surmodics.com
Exchange:

NASDAQ

Full time employees:

376

Industry:

Medical - Devices

Sector:

Healthcare

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

9924 West 74th Street
Eden Prairie, MN 55344-3523

CIK: 0000924717
ISIN: US8688731004
CUSIP: 868873100